Study to Examine the Effects of Oral Fenretinide
NCT06528457
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
15
Enrollment
INDUSTRY
Sponsor class
Conditions
Dengue
Interventions
DRUG:
ISLA101
DRUG:
Dengue 1 Live Virus Human Challenge (DENV-1-LVHC)
OTHER:
Placebo
Sponsor
Island Pharmaceuticals